Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Ritter

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
Urological Research|August 19, 2011
Initial experience with a newly developed antirefluxive ureter stentManuel Ritter, Patrick Krombach, Thomas Knoll, et al.
Cancers|September 5, 2020
Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell CarcinomaYing Zhang, Jörg Ellinger, Manuel Ritter, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 16, 2024
The relevance of circRNAs in serum of patients undergoing prostate biopsyLara Samirae, Philipp Krausewitz, Abdullah Alajati, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 19, 2021
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysisAlexander Cox, Yuri Tolkach, Johannes Stein, et al.
Urologia Internationalis|August 3, 2017
Prospective, Controlled Study of Invasiveness and Post-Aggression Metabolism in Patients Undergoing Robotic-Assisted Radical ProstatectomyAndreas Martinschek, Lisa Stumm, Manuel Ritter, et al.
Journal of Endourology|December 7, 2011
Standardized comparison of prostate morcellators using a new ex-vivo modelManuel Ritter, Patrick Krombach, Christian Bolenz, et al.
American Journal of Translational Research|April 14, 2023
Depletion of the m<sup>6</sup>A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinomaWei Hu, Niklas Klümper, Doris Schmidt, et al.
Investigative Radiology|May 24, 2014
Dose and image quality of cone-beam computed tomography as compared with conventional multislice computed tomography in abdominal imagingAlexander A Schegerer, Ursula Lechel, Manuel Ritter, et al.
Journal of Robotic Surgery|July 22, 2025
Association of fluid management during robotic-assisted radical laparoscopic prostatectomy with early surgical clinical outcomes: a risk factor for lymphocelesThomas Büttner, Marcus O Thudium, Manuel Ritter, et al.
Cancers|February 10, 2024
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA ApproachThomas Büttner, Dimo Dietrich, Romina Zarbl, et al.
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
Urological Research|August 19, 2011
Initial experience with a newly developed antirefluxive ureter stentManuel Ritter, Patrick Krombach, Thomas Knoll, et al.
Cancers|September 5, 2020
Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell CarcinomaYing Zhang, Jörg Ellinger, Manuel Ritter, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 16, 2024
The relevance of circRNAs in serum of patients undergoing prostate biopsyLara Samirae, Philipp Krausewitz, Abdullah Alajati, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 19, 2021
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysisAlexander Cox, Yuri Tolkach, Johannes Stein, et al.
Urologia Internationalis|August 3, 2017
Prospective, Controlled Study of Invasiveness and Post-Aggression Metabolism in Patients Undergoing Robotic-Assisted Radical ProstatectomyAndreas Martinschek, Lisa Stumm, Manuel Ritter, et al.
Journal of Endourology|December 7, 2011
Standardized comparison of prostate morcellators using a new ex-vivo modelManuel Ritter, Patrick Krombach, Christian Bolenz, et al.
American Journal of Translational Research|April 14, 2023
Depletion of the m<sup>6</sup>A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinomaWei Hu, Niklas Klümper, Doris Schmidt, et al.
Investigative Radiology|May 24, 2014
Dose and image quality of cone-beam computed tomography as compared with conventional multislice computed tomography in abdominal imagingAlexander A Schegerer, Ursula Lechel, Manuel Ritter, et al.
Journal of Robotic Surgery|July 22, 2025
Association of fluid management during robotic-assisted radical laparoscopic prostatectomy with early surgical clinical outcomes: a risk factor for lymphocelesThomas Büttner, Marcus O Thudium, Manuel Ritter, et al.
Cancers|February 10, 2024
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA ApproachThomas Büttner, Dimo Dietrich, Romina Zarbl, et al.
Pageof 20